16 research outputs found

    Novel Methods for Surface EMG Analysis and Exploration Based on Multi-Modal Gaussian Mixture Models

    Get PDF
    <div><p>This paper introduces a new method for data analysis of animal muscle activation during locomotion. It is based on fitting Gaussian mixture models (GMMs) to surface EMG data (sEMG). This approach enables researchers/users to isolate parts of the overall muscle activation within locomotion EMG data. Furthermore, it provides new opportunities for analysis and exploration of sEMG data by using the resulting Gaussian modes as atomic building blocks for a hierarchical clustering. In our experiments, composite peak models representing the general activation pattern per sensor location (one sensor on the long back muscle, three sensors on the gluteus muscle on each body side) were identified per individual for all 14 horses during walk and trot in the present study. Hereby we show the applicability of the method to identify composite peak models, which describe activation of different muscles throughout cycles of locomotion.</p></div

    Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

    Get PDF
    Background Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown. Methods Patients who were hospitalized for acute medical illnesses were randomly assigned to receive subcutaneous enoxaparin (at a dose of 40 mg once daily) for 10±4 days plus oral betrixaban placebo for 35 to 42 days or subcutaneous enoxaparin placebo for 10±4 days plus oral betrixaban (at a dose of 80 mg once daily) for 35 to 42 days. We performed sequential analyses in three prespecified, progressively inclusive cohorts: patients with an elevated d-dimer level (cohort 1), patients with an elevated d-dimer level or an age of at least 75 years (cohort 2), and all the enrolled patients (overall population cohort). The statistical analysis plan specified that if the between-group difference in any analysis in this sequence was not significant, the other analyses would be considered exploratory. The primary efficacy outcome was a composite of asymptomatic proximal deep-vein thrombosis and symptomatic venous thromboembolism. The principal safety outcome was major bleeding. Results A total of 7513 patients underwent randomization. In cohort 1, the primary efficacy outcome occurred in 6.9% of patients receiving betrixaban and 8.5% receiving enoxaparin (relative risk in the betrixaban group, 0.81; 95% confidence interval [CI], 0.65 to 1.00; P=0.054). The rates were 5.6% and 7.1%, respectively (relative risk, 0.80; 95% CI, 0.66 to 0.98; P=0.03) in cohort 2 and 5.3% and 7.0% (relative risk, 0.76; 95% CI, 0.63 to 0.92; P=0.006) in the overall population. (The last two analyses were considered to be exploratory owing to the result in cohort 1.) In the overall population, major bleeding occurred in 0.7% of the betrixaban group and 0.6% of the enoxaparin group (relative risk, 1.19; 95% CI, 0.67 to 2.12; P=0.55). Conclusions Among acutely ill medical patients with an elevated d-dimer level, there was no significant difference between extended-duration betrixaban and a standard regimen of enoxaparin in the prespecified primary efficacy outcome. However, prespecified exploratory analyses provided evidence suggesting a benefit for betrixaban in the two larger cohorts. (Funded by Portola Pharmaceuticals; APEX ClinicalTrials.gov number, NCT01583218. opens in new tab.

    Endothelin-1 expression after 9 hours of endotoxemia

    No full text

    From maturity to old age: tasks of daily life require a different muscle use in horses

    No full text
    In vertebrates ageing is characterised by reduced viscoelasticity of the ligamentous and tendineous structures and fibre changes in muscle. Also, some vertebral joint degeneration develops with ageing. The aim of this study was to apply dynamic time warping to compare the temporal characteristics of the surface electromyography (sEMG) data and to illustrate the differences in the pattern of muscle use during tasks of daily life in old and mature horses. In vivo kinematics (24 skin markers) and sEMG measurements of neck extensors and flexors were taken in five mature horses (aged 10±2 years, half of mean life expectancy) and five old horses (aged 25±5 years, older than the mean life expectancy). All horses had the same level of activity in the 12 months prior to the measurement. Tasks measured were neck flexion and neck extension as well as neutral neck position. Muscle activation, minimum and maximum muscle activation were collected. Quartiles of muscle activity based on the maximum observed activity of each muscle were calculated to document the relative increase of activity level during the task. Kinematics as well as overall muscle activity patterns were similar across horses and age groups. However, in the neutral position old horses showed increased extensor activity compared to mature horses, indicating that old equine muscle requires more activity to counteract gravity. Dynamic time warping specified optimal temporal alignments of time series, and different temporal performances were identified. The age groups differed during the flexion task, while neck extension and neutral neck position were more similar. The results of this study show that even in the second half of life and in the absence of muscle disuse the muscular strategy employed by horses continues to be adapted
    corecore